IGF1 and metabolic syndrome: Hyperinsulinemia increases IGF-1 and decreases IGFBP1/2 (that finally cause dyslipidemia or increased bioavailable estrogen), or induce β-cells failure and hyperglycemia to finally increase BC cell growth [63].